Bristol-Myers Squibb Company Price Today
Bristol-Myers Squibb Company
BMY
Healthcare
$103.81B
💰
Market Cap
13.6
💸
Price to Earnings
$3.8
🎉
EPS
+77
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
10 |
Strong Buy |
6 |
Hold |
12 |
Sell |
2 |
Strong Sell |
0 |
BMY Price Forecast Target
51.0 👉 90.0 +76%
BMY EPS Forecast
3.8 👉 7.8 +107%
Financials
Profit Margin
18 %
Revenue Growth
-2.2 %
Dividend
$ 2.28
Held Percent
0.1% - Insiders
78.2% - Institutions
21.7% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $10.4B
-
💰 Blackrock Inc. $8.8B
-
💰 JP Morgan Chase & Company $5.3B
-
💰 State Street Corporation $4.7B
-
💰 Capital International Investors $3.5B
Stock Ideas
Elon Musk Portfolio
Enter the visionary world of Elon Musk, a name that needs no introduction in the realms of innovation, entrepreneurship, and technology. With a trailblazing spirit and an unyielding drive, Musk has become a household name, propelling himself to extr…
Ron Baron Portfolio
Ron Baron is an American billionaire investor, entrepreneur, and the founder of Baron Capital Group, a well-known investment management firm. He is recognized for his long-term, growth-oriented investment approach and has built a successful track re…
Stanley Druckenmiller Portfolio
Stanley Druckenmiller is a legendary hedge fund manager who has made billions of dollars for his investors. His current portfolio is heavily invested in gold, silver, and other precious metals. He also owns shares in several technology and healthcar…
Bill Gates Portfolio
With a portfolio valued at over $18 billion, the Bill & Melinda Gates Foundation Trust holds the endowment and funds the Bill & Melinda Gates Foundation. Bill and Melinda are the trustees for the Foundation Trust, and the endowment is managed by a t…📮FAQ
Some Frequently Asked Questions.
The Bristol-Myers Squibb Company industry is Drug Manufacturers - General
The Bristol-Myers Squibb Company sector is Healthcare
The Bristol-Myers Squibb Company forecasted predicted Price to Earnings PE ratio is 6.6
The Bristol-Myers Squibb Company Price to Earnings PE ratio is 13.6
The Market Capitalization of Bristol-Myers Squibb Company is $103.81B
There are total of 2032377075 float shares with 78.2% held by Institutions and 0.1% held by insiders
The MBristol-Myers Squibb Company forecasted Earnings per Share EPS is $7.8
The Bristol-Myers Squibb Company Earnings per Share EPS is 3.8
The Bristol-Myers Squibb Company company has $36378000000 gross profits with 18 profit margins
The Bristol-Myers Squibb Company Earnings Growth is 0.24% with 0.201% quarterly earnings growth
The Bristol-Myers Squibb Company Revenue is $44935000064 with -0.022 revenue growth
The price target for Bristol-Myers Squibb Company stock is $90.0 for the high target and $55.0 for the low target
The consensus analyst recommendations for Bristol-Myers Squibb Company is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Bristol-Myers Squibb Company is Buy, with the following breakdown:
- Buy: 10
- Strong Buy: 6
- Hold: 12
- Sell: 2
- Strong Sell: 0
The Beta of Bristol-Myers Squibb Company is 0.3
The dividend of Bristol-Myers Squibb Company is $2.28
The dividend yield of Bristol-Myers Squibb Company is 0.044699997%
The biggest institutional and mutual fund holders of Bristol-Myers Squibb Company stock are
- Vanguard Group Inc
- Blackrock Inc.
- JP Morgan Chase & Company
- State Street Corporation
The Bristol-Myers Squibb Company ESG Score is 77, with the following breakdown:
- E: 0.34
- S: 14.93
- G: 7.56